Survival outcomes of ovarian cancer patients treated with secondary cytoreductive surgery for isolated lymph node recurrence: A systematic review of the literature-Reference-Cited by-同舟云学术

Survival outcomes of ovarian cancer patients treated with secondary cytoreductive surgery for isolated lymph node recurrence: A systematic review of the literature

Published:2019-09 Issue: Volume:69 Page:61-66
ISSN:1743-9191
Container-title:International Journal of Surgery
language:en
Short-container-title:International Journal of Surgery

Author:

Pergialiotis Vasilios^ORCID,Androutsou Anastasia,Papoutsi Eleni,Bellos Ioannis^ORCID,Thomakos Nikolaos,Haidopoulos Dimitrios,Rodolakis Alexandros

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference35 articles.

1. Miller KD, Samimi G, Runowicz CD, Gaudet MM, Jemal A, Siegel RL. CA cancer J. Clin. 10.3322/caac.21456.

2. Antiangiogenic drugs used with chemotherapy for patients with recurrent ovarian cancer: a meta-analysis;Yi;OncoTargets Ther.,2017

3. Angiogenesis inhibitors for patients with ovarian cancer: a meta-analysis of 12 randomized controlled trials;Li;Curr. Med. Res. Opin.,2016

4. The Era of PARP inhibitors in ovarian cancer: "Class Action" or not? A systematic review and meta-analysis;Staropoli;Crit. Rev. Oncol. Hematol.,2018

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mediastinal Metastasis Isolated in Ovarian Cancer: A Systematic Review;Life;2024-08-31

2. Major vessel resection for complete cytoreduction in primary advanced and recurrent ovarian malignancies: A case series and systematic review of the literature - pushing the boundaries in oncovascular surgery.;Gynecologic Oncology;2023-12

3. Minimally-Invasive Secondary Cytoreduction in Recurrent Ovarian Cancer;Cancers;2023-09-28

4. Récidive ganglionnaire isolée dans le cancer épithélial de l’ovaire : prise en charge et résultats;Journal de Chirurgie Viscérale;2023-06

5. Tertiary Cytoreduction for Isolated Lymphnode Recurrence (ILNR) Ovarian Cancer in a BRCA2 Mutated Patient: Our Experience and Prevalence of BRCA 1 or 2 Genes Mutational Status in ILNR;Medicina;2023-03-19